CALLICUTT JACK W bought GALT
November 10, 2025 · Form 4 insider transaction
CALLICUTT JACK W bought 1,675 shares of Galectin Therapeutics Inc. at $1.11 per share, a transaction worth $1.9K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
1,675
Price
$1.11
Total value
$1.9K
InsiderCALLICUTT JACK W
RoleOfficer
SecurityCommon stock
Transaction codeM: Option exercise
Transaction dateNovember 10, 2025
Filing dateNovember 12, 2025
Shares owned after9,289
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The reported transaction was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on April 17, 2025, as disclosed in the Issuer?s Quarterly Report on Form 10-Q, filed with the SEC on August 14, 2025.